Welcome to our dedicated page for DaVita news (Ticker: $DVA), a resource for investors and traders seeking the latest updates and insights on DaVita stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DaVita's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DaVita's position in the market.
Rhea-AI Summary
DaVita Inc. (DVA) awards Western Governors University's (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in the Start Early program, aimed at increasing nursing degree completion rates. The program addresses the critical nursing workforce shortage in the U.S. and will provide financial support, scholarships, and resources to nursing students facing barriers to education.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
-
Rhea-AI Summary
DaVita (DVA) successfully raised over $750,000 through its 2023 Move It With Purpose event, with a record-breaking participation of more than 6,400 movers logging nearly 400,000 total miles. Since 2007, DaVita has raised over $15 million for Bridge of Life, a nonprofit supporting chronic disease prevention and treatment globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.86%
Tags
-
Rhea-AI Summary
DaVita Inc. (NYSE: DVA) reports strong Q3 financial and operating results, with consolidated revenues of $3.1 billion and operating income of $496 million. Diluted earnings per share was $2.62 and adjusted diluted earnings per share was $2.85.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.89%
Tags
Rhea-AI Summary
DaVita Clinical Research (DCR) is presenting the findings of five new research projects at the American Society of Nephrology (ASN)'s annual 'Kidney Week' in Philadelphia. The studies focus on driving health equity and reducing hospitalizations. The research includes studies on barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients. DaVita is committed to improving patient care and increasing kidney transplantation and in-home dialysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
-
Rhea-AI Summary
DaVita Inc. and Google Cloud have collaborated to create a new clinical operating system called Center Without Walls (CWOW) to streamline kidney care for over 200,000 DaVita patients. CWOW, built on Google Cloud infrastructure and utilizing AI and analytics tools, allows caregivers to access data and improve workflows. The platform aims to improve clinical outcomes and increase collaboration between DaVita's partners and care teams.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.09%
Tags
-
Rhea-AI Summary
DaVita Inc. to hold quarterly conference call to discuss third quarter results on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.09%
Tags
Rhea-AI Summary
DaVita responds to Novo Nordisk's FLOW study on Ozempic and its potential benefits for kidney disease patients
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.77%
Tags
-
News
Rhea-AI Summary
DaVita Inc. launches 2023 Health Tour to raise awareness of risk factors for chronic kidney disease and provide free health screenings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.09%
Tags
-
Rhea-AI Summary
DaVita Inc. collaborates with Adtalem Global Education to launch the 'Introduction to Nephrology Nursing' curriculum at Chamberlain University, aiming to address the shortage of nurses in the U.S. and provide career pathways in nephrology nursing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
Rhea-AI Summary
DaVita Inc. to participate in fireside chat with UBS
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
DaVita Inc.
NYSE:DVA
DVA Rankings
DVA Stock Data
12.47B
48.02M
45.06%
51.61%
4.74%
Kidney Dialysis Centers
Health Care and Social Assistance
United States of America
DENVER
About DVA
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,